Why the future of marijuana legalization remains hazy despite high public support 
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal 
Locked up then locked out: how NZ’s bank rules make life for ex-prisoners even harder 
Broadcom Eyes $35 Billion AI Chip Financing Deal With Apollo and Blackstone 
Gold Prices Hold Firm as Traders Watch U.S.-Iran Ceasefire and Trump-Xi Talks 
The ghost of Robodebt – Federal Court rules billions of dollars in welfare debts must be recalculated 
AI is driving down the price of knowledge – universities have to rethink what they offer 
Sony Forecasts Lower 2027 Profit Despite Strong Music and Sensor Growth 
Reliance Industries Reworks Jio IPO Into Fresh Share Sale Amid Valuation Talks 
Want to cut your energy bills? Here’s how five experts are doing it 
China Inflation Jumps as Iran Conflict Drives Energy Costs Higher 
The pandemic is still disrupting young people’s careers 
Heritage, desire and diplomacy: why China still values scotch whisky 
Trump Says Iran Ceasefire ‘On Life Support’ as Oil Prices Surge Above $104 
Oil Prices Rise as Dollar Gains Ahead of Key U.S. Inflation Data 
Asian Currencies Slide as Iran Tensions Boost Dollar and Oil Prices 
Armani Group Eyes Strategic Stake Sale to Luxury Giants 
Bubs Australia will manufacture and distribute Bubs’ Chinese-label goat milk infant formula in China according to new Chinese standards. under an agreement with Heilongjiang Ubeite Dairy Group (HUG).
The new standards will come into effect in February 2023 .
The “ultra-premium” infant formula has been specially developed for Chinese infants using easily-digestible A2 goat-milk protein, sn2 palmitate (OPO), lactoferrin prebiotics, and nucleotides.
HUG has started submission with the State Administration for Market Regulation (SAMR) to renew its registration in line with China’s new GB standards for exclusive use under the Bubs brand.
According to Kristy Carr, Bubs founder and CEO, they have built strong brand trust and loyalty with Chinese families through marketing and selling Bubs English label infant formula products via the crossborder eCommerce channel, which accounts for around 20 percent of total Chinese infant formula sales.
If approved by SAMR, the formula will give Bubs access to the remaining 80 percent of China’s $25.9 billion infant formula market.
Bubs will also enter into a joint venture agreement, where it will hold a 75 percent interest, with Zhitong Health Technology to distribute its Chinese label goat infant formula products.
Bubs Australia expects to launch its product in the second half of FY23, subject to receiving SAMR approval.
